Biotech · Private company
Ebima Clifford Okundaye
Track this companyFree. Adds Ebima Clifford Okundaye to your Dealase workspace and tells you when its record changes.
Clinical trials32 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- QRX-3Phase 3 · Acute Renal Failure (ARF)ClinicalTrials.gov · fetched Nov 12, 2026
- QRX-3Phase 3 · Chronic Kidney DiseasesClinicalTrials.gov · fetched Nov 12, 2026
- QRX-3Phase 2 · Chronic Kidney Disease Stages 3-5ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)PHASE2_PHASE3 · NOT_YET_RECRUITING · started Jun 30, 2026ClinicalTrials.gov NCT07161843 · fetched Nov 12, 2026
- Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease ProgressionPHASE2_PHASE3 · NOT_YET_RECRUITING · started Oct 1, 2025ClinicalTrials.gov NCT06866236 · fetched Nov 12, 2026
- Role of QRX-3 in Chronic Kidney Disease Patients in Outpatients ClinicsPHASE2 · COMPLETED · started Mar 1, 2023ClinicalTrials.gov NCT06948292 · fetched Nov 12, 2026